Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers.

Int J Oncol · 2022 · PMC8878637 · PMID 35191515

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The mean number of mitosis (per high power field) was found lower in the birinapant (0.6377) and co-therapy (0.720)-treated groups compared to the vehicle (1.533) and carboplatin (1.388) groups, although it did not reach statistical significance ( Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.